Science decoded, the business angle included.
Ingredient markets, clinical studies under scrutiny, regulatory, AI visibility. Every insight is sourced — PubMed, EFSA, dated reports — and ends with what it changes for your pipeline.
Insights — Page 2
Precision microbiome: the ingredient opportunity in 2026
Precision microbiome: why the loss of microbial functions linked to modern life opens up an innovation space for pro- and prebiotics.
Read the insight
Women's health: what ADM's white paper brings, and where the evidence stops
ADM's white paper, Elevating Women’s Health: Solutions for Every Step, is robust and useful. What remains is to separately read what pertains to the sales pitch.
Read the insight
Platforms have overtaken television. In nutrition and health, it's trust that's becoming scarce.
Social media, video, influencers: platforms dominate our attention. In nutrition and health, the scarcest resource remains trust.
Read the insight
The Nutri-Score Trial: What the Lactalis Offensive Reveals
The Nutri-Score trial brought by Lactalis before the CJEU exposes the legal flaws of a labelling system that constrains your product strategies in Europe.
Read the insight
Calcium and vitamin D: science says no to universal supplementation, yes to nuance
Calcium and vitamin D: what does the science really say about supplementation? A review nuances the benefits and calls for personalised recommendations.
Read the insight
The AHA's 9 Cardiovascular Recommendations 2026
The AHA 2026 is restructuring its 9 cardiovascular priorities. Discover the direct implications for your ingredients and your B2B strategy.
Read the insight
Carbohydrates: quantity no longer matters, quality kills (or protects)
The quality of carbohydrates better predicts the risk of type 2 diabetes than their quantity. Prospective study of 213,704 adults, 36 years of follow-up.
Read the insight
Protein ingredients: what GLP-1 drugs are changing
Protein ingredients are gaining ground as a result of GLP-1 drugs: –21 % calories, +11 % protein. What this means for food R&D.
Read the insight
Late-night meals desynchronise the gut's circadian clock
Late-night meals disrupt the gut's circadian clocks. Risks for shift workers, jet lag and chrono-nutritional approaches.
Read the insight
CMO's number 1 priority in 2026: Brand. AI decides who makes the shortlist.
In 2026, CMOs will rank the brand as priority number 1. In B2B food, AI will pre-select suppliers before the first contact. What this changes.
Read the insight
Philips Future Health Index 2026: AI saves clinicians 16 days a year... but training deficit is a concern
The Philips Future Health Index 2026 shows that AI saves clinicians 16 days a year, despite a training shortfall among 70 % of healthcare professionals.
Read the insight
GLP-1 and diet: what foods for Ozempic and Wegovy users?
GLP-1 medications (Ozempic, Wegovy) change eating habits. Which foods should be favoured? What are the opportunities for the food industry?
Read the insight